PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSMUSG00000023852.15 | Chd1 |
Pml
|
ENSMUSG00000036986.17 | Pml |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pml | mm39_v1_chr9_-_58156982_58157078 | -0.22 | 5.9e-02 | Click! |
Chd1 | mm39_v1_chr17_+_15925205_15925256 | -0.01 | 9.4e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_-_66158445 | 41.36 |
ENSMUST00000070256.9
|
Kcnq3
|
potassium voltage-gated channel, subfamily Q, member 3 |
chr6_-_114018982 | 35.08 |
ENSMUST00000101045.10
|
Atp2b2
|
ATPase, Ca++ transporting, plasma membrane 2 |
chr16_-_67417768 | 29.03 |
ENSMUST00000114292.8
ENSMUST00000120898.8 |
Cadm2
|
cell adhesion molecule 2 |
chr11_-_4696778 | 28.18 |
ENSMUST00000009219.3
|
Cabp7
|
calcium binding protein 7 |
chr16_-_67417687 | 27.96 |
ENSMUST00000120594.8
|
Cadm2
|
cell adhesion molecule 2 |
chr9_-_86762467 | 27.83 |
ENSMUST00000074501.12
ENSMUST00000239074.2 ENSMUST00000098495.10 ENSMUST00000036347.13 ENSMUST00000074468.13 |
Snap91
|
synaptosomal-associated protein 91 |
chr15_-_79688910 | 27.82 |
ENSMUST00000175858.10
ENSMUST00000023057.10 |
Nptxr
|
neuronal pentraxin receptor |
chr15_+_87509413 | 27.50 |
ENSMUST00000068088.8
|
Tafa5
|
TAFA chemokine like family member 5 |
chr12_+_44375747 | 25.16 |
ENSMUST00000020939.16
ENSMUST00000220126.2 |
Nrcam
|
neuronal cell adhesion molecule |
chr16_+_17945471 | 24.88 |
ENSMUST00000059589.6
|
Rtn4r
|
reticulon 4 receptor |
chr15_+_74388044 | 24.35 |
ENSMUST00000042035.16
|
Adgrb1
|
adhesion G protein-coupled receptor B1 |
chr14_-_39194782 | 24.31 |
ENSMUST00000168810.9
ENSMUST00000173780.2 ENSMUST00000166968.9 |
Nrg3
|
neuregulin 3 |
chrX_-_156826262 | 23.76 |
ENSMUST00000026750.15
ENSMUST00000112513.2 |
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2 |
chr15_-_25413838 | 23.64 |
ENSMUST00000058845.9
|
Basp1
|
brain abundant, membrane attached signal protein 1 |
chr7_+_123582021 | 23.47 |
ENSMUST00000106437.2
|
Hs3st4
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
chr10_+_90665270 | 23.16 |
ENSMUST00000182202.8
ENSMUST00000182966.8 |
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr12_+_44375665 | 23.11 |
ENSMUST00000110748.4
|
Nrcam
|
neuronal cell adhesion molecule |
chr14_-_78970160 | 22.90 |
ENSMUST00000226342.3
|
Dgkh
|
diacylglycerol kinase, eta |
chr17_+_9020522 | 22.69 |
ENSMUST00000089085.10
|
Pde10a
|
phosphodiesterase 10A |
chr10_+_126914755 | 22.55 |
ENSMUST00000039259.7
ENSMUST00000217941.2 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr13_-_25454058 | 22.35 |
ENSMUST00000057866.13
|
Nrsn1
|
neurensin 1 |
chr4_+_129878627 | 22.13 |
ENSMUST00000120204.8
|
Adgrb2
|
adhesion G protein-coupled receptor B2 |
chr4_+_129878890 | 21.59 |
ENSMUST00000106017.8
ENSMUST00000121049.8 |
Adgrb2
|
adhesion G protein-coupled receptor B2 |
chr15_+_83664196 | 21.51 |
ENSMUST00000046168.12
|
Mpped1
|
metallophosphoesterase domain containing 1 |
chr7_+_57240894 | 21.45 |
ENSMUST00000039697.14
|
Gabrb3
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
chr16_-_20440005 | 21.44 |
ENSMUST00000052939.4
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr8_+_122457302 | 21.19 |
ENSMUST00000026357.12
|
Jph3
|
junctophilin 3 |
chr6_-_120470768 | 21.12 |
ENSMUST00000178687.2
|
Tmem121b
|
transmembrane protein 121B |
chr9_+_110074574 | 20.82 |
ENSMUST00000197850.5
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr6_-_42301574 | 20.77 |
ENSMUST00000031891.15
ENSMUST00000143278.8 |
Fam131b
|
family with sequence similarity 131, member B |
chr4_-_129015493 | 20.23 |
ENSMUST00000135763.2
ENSMUST00000149763.3 ENSMUST00000164649.8 |
Hpca
|
hippocalcin |
chr8_-_125161061 | 20.03 |
ENSMUST00000140012.8
|
Pgbd5
|
piggyBac transposable element derived 5 |
chr3_-_80820835 | 19.93 |
ENSMUST00000107743.8
ENSMUST00000029654.15 |
Glrb
|
glycine receptor, beta subunit |
chr2_-_163760603 | 19.84 |
ENSMUST00000044734.3
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr17_+_70276210 | 19.69 |
ENSMUST00000060072.12
|
Dlgap1
|
DLG associated protein 1 |
chrX_+_158197568 | 19.50 |
ENSMUST00000112471.9
|
Map7d2
|
MAP7 domain containing 2 |
chrX_-_6085069 | 19.26 |
ENSMUST00000103006.4
|
Nudt10
|
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
chr15_+_88943916 | 19.25 |
ENSMUST00000161372.2
ENSMUST00000162424.2 |
Panx2
|
pannexin 2 |
chr14_-_29443792 | 19.23 |
ENSMUST00000022567.9
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chr14_+_70314727 | 19.20 |
ENSMUST00000225200.2
|
Egr3
|
early growth response 3 |
chr15_+_39061612 | 19.18 |
ENSMUST00000082054.12
ENSMUST00000227243.2 ENSMUST00000042917.10 |
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr1_-_170417354 | 18.88 |
ENSMUST00000160456.8
|
Nos1ap
|
nitric oxide synthase 1 (neuronal) adaptor protein |
chr7_-_30144933 | 18.65 |
ENSMUST00000006828.9
|
Aplp1
|
amyloid beta (A4) precursor-like protein 1 |
chr1_-_33946802 | 18.56 |
ENSMUST00000115161.8
ENSMUST00000129464.8 ENSMUST00000062289.11 |
Bend6
|
BEN domain containing 6 |
chr1_+_66507523 | 18.49 |
ENSMUST00000061620.17
ENSMUST00000212557.3 |
Unc80
|
unc-80, NALCN activator |
chr15_+_74435587 | 18.44 |
ENSMUST00000185682.7
ENSMUST00000170845.8 ENSMUST00000187599.2 |
Adgrb1
|
adhesion G protein-coupled receptor B1 |
chr9_-_56703422 | 18.18 |
ENSMUST00000210032.2
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr8_+_85141975 | 18.16 |
ENSMUST00000121390.8
ENSMUST00000122053.2 |
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr1_+_181180183 | 18.07 |
ENSMUST00000161880.8
ENSMUST00000027795.14 |
Cnih3
|
cornichon family AMPA receptor auxiliary protein 3 |
chrX_+_5959507 | 18.07 |
ENSMUST00000103007.4
|
Nudt11
|
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
chr4_-_91260265 | 17.42 |
ENSMUST00000107110.8
ENSMUST00000008633.15 ENSMUST00000107118.8 |
Elavl2
|
ELAV like RNA binding protein 1 |
chr11_+_83300481 | 17.40 |
ENSMUST00000175848.8
ENSMUST00000108140.10 |
Rasl10b
|
RAS-like, family 10, member B |
chr5_+_37025810 | 17.37 |
ENSMUST00000031003.11
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr15_+_30173197 | 17.32 |
ENSMUST00000226119.2
|
Ctnnd2
|
catenin (cadherin associated protein), delta 2 |
chr6_-_122463422 | 17.21 |
ENSMUST00000068242.9
|
Rimklb
|
ribosomal modification protein rimK-like family member B |
chr9_+_74978429 | 17.20 |
ENSMUST00000123128.8
|
Myo5a
|
myosin VA |
chr6_-_42301488 | 17.18 |
ENSMUST00000095974.4
|
Fam131b
|
family with sequence similarity 131, member B |
chr7_-_84059321 | 17.16 |
ENSMUST00000085077.5
ENSMUST00000207769.2 |
Arnt2
|
aryl hydrocarbon receptor nuclear translocator 2 |
chr4_-_139974062 | 17.13 |
ENSMUST00000039331.9
|
Igsf21
|
immunoglobulin superfamily, member 21 |
chr8_+_94537460 | 17.09 |
ENSMUST00000034198.15
ENSMUST00000125716.8 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr2_-_35869636 | 17.04 |
ENSMUST00000028248.11
ENSMUST00000112976.9 |
Ttll11
|
tubulin tyrosine ligase-like family, member 11 |
chr10_-_43050516 | 16.98 |
ENSMUST00000040275.9
|
Sobp
|
sine oculis binding protein |
chr3_-_57754901 | 16.94 |
ENSMUST00000120289.3
|
Pfn2
|
profilin 2 |
chr5_-_108515740 | 16.87 |
ENSMUST00000197216.3
|
Gm42517
|
predicted gene 42517 |
chr16_+_80997580 | 16.79 |
ENSMUST00000037785.14
ENSMUST00000067602.5 |
Ncam2
|
neural cell adhesion molecule 2 |
chr15_+_83664175 | 16.78 |
ENSMUST00000163723.8
|
Mpped1
|
metallophosphoesterase domain containing 1 |
chr10_-_70435114 | 16.58 |
ENSMUST00000046513.10
|
Phyhipl
|
phytanoyl-CoA hydroxylase interacting protein-like |
chr6_-_124746510 | 16.52 |
ENSMUST00000149652.2
ENSMUST00000112476.8 ENSMUST00000004378.15 |
Eno2
|
enolase 2, gamma neuronal |
chr14_+_70314652 | 16.49 |
ENSMUST00000035908.3
|
Egr3
|
early growth response 3 |
chr2_+_145009625 | 16.46 |
ENSMUST00000110007.8
|
Slc24a3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
chr6_+_114108190 | 15.92 |
ENSMUST00000032451.9
|
Slc6a11
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
chr13_-_69147639 | 15.82 |
ENSMUST00000022013.8
|
Adcy2
|
adenylate cyclase 2 |
chr17_+_70276382 | 15.68 |
ENSMUST00000146730.9
|
Dlgap1
|
DLG associated protein 1 |
chr6_+_115111872 | 15.59 |
ENSMUST00000009538.12
ENSMUST00000203450.2 |
Syn2
|
synapsin II |
chr4_-_133225849 | 15.50 |
ENSMUST00000125541.2
|
Trnp1
|
TMF1-regulated nuclear protein 1 |
chr6_+_115111860 | 15.48 |
ENSMUST00000169345.4
|
Syn2
|
synapsin II |
chr2_+_119629995 | 15.48 |
ENSMUST00000028763.10
|
Tyro3
|
TYRO3 protein tyrosine kinase 3 |
chr5_-_100307130 | 15.39 |
ENSMUST00000139520.3
|
Tmem150c
|
transmembrane protein 150C |
chr7_+_4693759 | 15.38 |
ENSMUST00000048248.9
|
Brsk1
|
BR serine/threonine kinase 1 |
chr19_+_43428843 | 15.31 |
ENSMUST00000223787.2
ENSMUST00000165311.3 |
Cnnm1
|
cyclin M1 |
chr17_+_26028059 | 15.27 |
ENSMUST00000045692.9
|
Fbxl16
|
F-box and leucine-rich repeat protein 16 |
chrX_+_135567124 | 15.20 |
ENSMUST00000060904.11
ENSMUST00000113100.2 ENSMUST00000128040.2 |
Tceal3
|
transcription elongation factor A (SII)-like 3 |
chr9_-_86762450 | 15.06 |
ENSMUST00000191290.3
|
Snap91
|
synaptosomal-associated protein 91 |
chrX_+_10351360 | 14.94 |
ENSMUST00000076354.13
ENSMUST00000115526.2 |
Tspan7
|
tetraspanin 7 |
chr6_-_124746468 | 14.89 |
ENSMUST00000204896.3
|
Eno2
|
enolase 2, gamma neuronal |
chr11_-_87249837 | 14.88 |
ENSMUST00000055438.5
|
Ppm1e
|
protein phosphatase 1E (PP2C domain containing) |
chr17_-_64638887 | 14.88 |
ENSMUST00000172818.8
|
Pja2
|
praja ring finger ubiquitin ligase 2 |
chr17_+_24707711 | 14.86 |
ENSMUST00000024958.9
ENSMUST00000234717.2 |
Caskin1
|
CASK interacting protein 1 |
chr4_+_101353742 | 14.84 |
ENSMUST00000154120.9
ENSMUST00000106930.8 |
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6 |
chr15_-_78004211 | 14.81 |
ENSMUST00000019290.3
|
Cacng2
|
calcium channel, voltage-dependent, gamma subunit 2 |
chr7_+_24181416 | 14.80 |
ENSMUST00000068023.8
|
Cadm4
|
cell adhesion molecule 4 |
chr7_+_43959637 | 14.68 |
ENSMUST00000107938.8
|
Shank1
|
SH3 and multiple ankyrin repeat domains 1 |
chr7_+_141503719 | 14.65 |
ENSMUST00000105989.9
ENSMUST00000075528.12 ENSMUST00000174499.8 |
Brsk2
|
BR serine/threonine kinase 2 |
chr17_-_64638814 | 14.53 |
ENSMUST00000172733.2
|
Pja2
|
praja ring finger ubiquitin ligase 2 |
chr7_+_3381434 | 14.53 |
ENSMUST00000092891.6
|
Cacng7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr9_-_56542908 | 14.49 |
ENSMUST00000114256.2
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr4_-_46991842 | 14.31 |
ENSMUST00000107749.4
|
Gabbr2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr2_-_131404203 | 14.30 |
ENSMUST00000103184.4
|
Adra1d
|
adrenergic receptor, alpha 1d |
chr11_-_118800314 | 14.22 |
ENSMUST00000117731.8
ENSMUST00000106278.9 ENSMUST00000120061.8 ENSMUST00000017576.11 |
Rbfox3
|
RNA binding protein, fox-1 homolog (C. elegans) 3 |
chr11_+_54195006 | 14.19 |
ENSMUST00000108904.10
ENSMUST00000108905.10 |
Acsl6
|
acyl-CoA synthetase long-chain family member 6 |
chr2_+_90716204 | 14.19 |
ENSMUST00000111466.3
|
C1qtnf4
|
C1q and tumor necrosis factor related protein 4 |
chr4_-_124755964 | 14.19 |
ENSMUST00000064444.8
|
Maneal
|
mannosidase, endo-alpha-like |
chr11_-_119438569 | 14.18 |
ENSMUST00000026670.5
|
Nptx1
|
neuronal pentraxin 1 |
chr6_+_99669640 | 14.17 |
ENSMUST00000101122.3
|
Gpr27
|
G protein-coupled receptor 27 |
chr8_+_120173458 | 14.16 |
ENSMUST00000098363.10
|
Necab2
|
N-terminal EF-hand calcium binding protein 2 |
chr17_+_8559539 | 14.13 |
ENSMUST00000163887.2
|
Prr18
|
proline rich 18 |
chr9_-_52591030 | 14.12 |
ENSMUST00000213937.2
|
AI593442
|
expressed sequence AI593442 |
chrX_+_72546680 | 14.05 |
ENSMUST00000033744.12
ENSMUST00000088429.8 ENSMUST00000114479.2 |
Atp2b3
|
ATPase, Ca++ transporting, plasma membrane 3 |
chr3_+_136375839 | 14.00 |
ENSMUST00000070198.14
|
Ppp3ca
|
protein phosphatase 3, catalytic subunit, alpha isoform |
chr5_+_19431976 | 13.99 |
ENSMUST00000197354.5
ENSMUST00000088516.10 ENSMUST00000197443.5 |
Magi2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr3_-_152373997 | 13.93 |
ENSMUST00000045262.11
|
Ak5
|
adenylate kinase 5 |
chr12_-_76869282 | 13.93 |
ENSMUST00000021459.14
|
Rab15
|
RAB15, member RAS oncogene family |
chr17_-_45860580 | 13.91 |
ENSMUST00000180252.3
|
Tmem151b
|
transmembrane protein 151B |
chr14_+_9646630 | 13.89 |
ENSMUST00000112658.8
ENSMUST00000112657.9 ENSMUST00000177814.2 ENSMUST00000067491.14 |
Cadps
|
Ca2+-dependent secretion activator |
chr7_-_138768374 | 13.89 |
ENSMUST00000016125.12
|
Stk32c
|
serine/threonine kinase 32C |
chr4_+_127062924 | 13.74 |
ENSMUST00000046659.14
|
Dlgap3
|
DLG associated protein 3 |
chr2_+_25132941 | 13.71 |
ENSMUST00000114355.2
ENSMUST00000060818.2 |
Rnf208
|
ring finger protein 208 |
chr4_+_33924632 | 13.69 |
ENSMUST00000057188.7
|
Cnr1
|
cannabinoid receptor 1 (brain) |
chr5_-_139115914 | 13.65 |
ENSMUST00000129851.8
|
Prkar1b
|
protein kinase, cAMP dependent regulatory, type I beta |
chr3_+_96088467 | 13.64 |
ENSMUST00000035371.9
|
Sv2a
|
synaptic vesicle glycoprotein 2 a |
chr8_+_96404713 | 13.63 |
ENSMUST00000041318.14
|
Ndrg4
|
N-myc downstream regulated gene 4 |
chr17_-_24908874 | 13.61 |
ENSMUST00000007236.5
|
Syngr3
|
synaptogyrin 3 |
chr2_+_164802729 | 13.58 |
ENSMUST00000202623.4
|
Slc12a5
|
solute carrier family 12, member 5 |
chr14_+_67148619 | 13.48 |
ENSMUST00000089236.11
ENSMUST00000122431.3 |
Pnma2
|
paraneoplastic antigen MA2 |
chr2_+_164802766 | 13.44 |
ENSMUST00000202223.4
|
Slc12a5
|
solute carrier family 12, member 5 |
chr12_+_16703383 | 13.26 |
ENSMUST00000221596.2
ENSMUST00000111064.3 ENSMUST00000220892.2 |
Ntsr2
|
neurotensin receptor 2 |
chr15_-_90934021 | 13.24 |
ENSMUST00000109287.4
ENSMUST00000067205.16 ENSMUST00000088614.13 |
Kif21a
|
kinesin family member 21A |
chr1_-_184731672 | 13.22 |
ENSMUST00000192657.2
ENSMUST00000027929.10 |
Mark1
|
MAP/microtubule affinity regulating kinase 1 |
chr10_+_90665399 | 13.14 |
ENSMUST00000179694.9
|
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr4_+_138181616 | 13.12 |
ENSMUST00000050918.4
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr5_+_37025926 | 13.06 |
ENSMUST00000201156.2
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr12_+_110413677 | 12.94 |
ENSMUST00000220509.2
|
Ppp2r5c
|
protein phosphatase 2, regulatory subunit B', gamma |
chr15_-_79389442 | 12.86 |
ENSMUST00000057801.8
|
Kcnj4
|
potassium inwardly-rectifying channel, subfamily J, member 4 |
chr3_+_13536696 | 12.81 |
ENSMUST00000191806.3
ENSMUST00000193117.3 |
Ralyl
|
RALY RNA binding protein-like |
chr4_+_155819257 | 12.78 |
ENSMUST00000147721.8
ENSMUST00000127188.3 |
Tmem240
|
transmembrane protein 240 |
chr4_+_107659361 | 12.77 |
ENSMUST00000106731.4
|
Lrp8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
chr19_-_42420216 | 12.75 |
ENSMUST00000048630.8
ENSMUST00000238290.2 |
Crtac1
|
cartilage acidic protein 1 |
chr5_+_37399284 | 12.73 |
ENSMUST00000202434.4
ENSMUST00000114158.9 |
Crmp1
|
collapsin response mediator protein 1 |
chrX_-_58179754 | 12.68 |
ENSMUST00000033473.12
|
Fgf13
|
fibroblast growth factor 13 |
chr7_+_4693603 | 12.67 |
ENSMUST00000120836.8
|
Brsk1
|
BR serine/threonine kinase 1 |
chr18_-_25887173 | 12.66 |
ENSMUST00000225477.2
|
Celf4
|
CUGBP, Elav-like family member 4 |
chr2_+_38229270 | 12.59 |
ENSMUST00000143783.9
|
Lhx2
|
LIM homeobox protein 2 |
chr12_+_108300599 | 12.57 |
ENSMUST00000021684.6
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr9_+_74978859 | 12.55 |
ENSMUST00000136731.8
|
Myo5a
|
myosin VA |
chr7_+_126422458 | 12.51 |
ENSMUST00000079423.7
|
Tlcd3b
|
TLC domain containing 3B |
chr5_-_23880939 | 12.50 |
ENSMUST00000196388.5
|
Srpk2
|
serine/arginine-rich protein specific kinase 2 |
chr5_-_5430172 | 12.48 |
ENSMUST00000030763.13
|
Cdk14
|
cyclin-dependent kinase 14 |
chr2_+_92430043 | 12.46 |
ENSMUST00000065797.7
|
Chst1
|
carbohydrate sulfotransferase 1 |
chr7_+_18659787 | 12.44 |
ENSMUST00000032571.10
ENSMUST00000220302.2 |
Nova2
|
NOVA alternative splicing regulator 2 |
chr2_-_92231598 | 12.40 |
ENSMUST00000050312.3
|
Mapk8ip1
|
mitogen-activated protein kinase 8 interacting protein 1 |
chr8_+_85142413 | 12.38 |
ENSMUST00000215756.2
|
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr2_+_164810139 | 12.34 |
ENSMUST00000202479.4
|
Slc12a5
|
solute carrier family 12, member 5 |
chr17_-_27732364 | 12.29 |
ENSMUST00000118161.3
|
Grm4
|
glutamate receptor, metabotropic 4 |
chr9_+_74978668 | 12.26 |
ENSMUST00000155282.9
|
Myo5a
|
myosin VA |
chr12_-_72283465 | 12.23 |
ENSMUST00000021497.16
ENSMUST00000137990.2 |
Rtn1
|
reticulon 1 |
chr17_-_24752683 | 12.17 |
ENSMUST00000061764.14
|
Rab26
|
RAB26, member RAS oncogene family |
chr10_-_77254041 | 12.15 |
ENSMUST00000020496.14
ENSMUST00000098374.9 ENSMUST00000105406.8 |
Adarb1
|
adenosine deaminase, RNA-specific, B1 |
chr7_+_141503411 | 12.13 |
ENSMUST00000078200.12
ENSMUST00000018971.15 |
Brsk2
|
BR serine/threonine kinase 2 |
chrX_-_20787150 | 11.94 |
ENSMUST00000081893.7
ENSMUST00000115345.8 |
Syn1
|
synapsin I |
chr15_+_89383799 | 11.92 |
ENSMUST00000109309.9
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr15_+_100768806 | 11.87 |
ENSMUST00000201549.4
ENSMUST00000108908.6 |
Scn8a
|
sodium channel, voltage-gated, type VIII, alpha |
chr5_+_107551362 | 11.87 |
ENSMUST00000049146.12
|
Ephx4
|
epoxide hydrolase 4 |
chr6_-_77956635 | 11.86 |
ENSMUST00000161846.8
ENSMUST00000160894.8 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr11_+_54194831 | 11.81 |
ENSMUST00000000145.12
ENSMUST00000138515.8 |
Acsl6
|
acyl-CoA synthetase long-chain family member 6 |
chr7_-_27095964 | 11.81 |
ENSMUST00000108363.8
|
Sptbn4
|
spectrin beta, non-erythrocytic 4 |
chr7_+_44078366 | 11.81 |
ENSMUST00000127790.8
|
Lrrc4b
|
leucine rich repeat containing 4B |
chr6_-_88852017 | 11.80 |
ENSMUST00000145944.3
|
Podxl2
|
podocalyxin-like 2 |
chr4_+_107659474 | 11.79 |
ENSMUST00000106733.10
ENSMUST00000238651.2 ENSMUST00000030356.10 ENSMUST00000238421.2 ENSMUST00000126573.8 ENSMUST00000238569.2 ENSMUST00000106732.10 |
Lrp8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
chr1_+_163607143 | 11.79 |
ENSMUST00000077642.12
ENSMUST00000027877.7 |
Kifap3
|
kinesin-associated protein 3 |
chrX_+_59591614 | 11.78 |
ENSMUST00000117865.3
|
Gm715
|
predicted gene 715 |
chr2_+_28095660 | 11.75 |
ENSMUST00000102879.4
ENSMUST00000028177.11 |
Olfm1
|
olfactomedin 1 |
chr5_+_16139683 | 11.75 |
ENSMUST00000167946.9
|
Cacna2d1
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
chr1_+_66214445 | 11.75 |
ENSMUST00000114017.8
ENSMUST00000114015.8 |
Map2
|
microtubule-associated protein 2 |
chr10_+_90665639 | 11.74 |
ENSMUST00000179337.9
|
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr5_+_37403098 | 11.70 |
ENSMUST00000031004.11
|
Crmp1
|
collapsin response mediator protein 1 |
chr1_-_172034251 | 11.69 |
ENSMUST00000155109.2
|
Pea15a
|
phosphoprotein enriched in astrocytes 15A |
chr17_+_27904155 | 11.66 |
ENSMUST00000231669.2
ENSMUST00000097360.3 ENSMUST00000231236.2 |
Pacsin1
|
protein kinase C and casein kinase substrate in neurons 1 |
chrX_+_98864627 | 11.63 |
ENSMUST00000096363.3
|
Tmem28
|
transmembrane protein 28 |
chr16_-_67417381 | 11.58 |
ENSMUST00000123266.2
|
Cadm2
|
cell adhesion molecule 2 |
chr15_-_74544409 | 11.58 |
ENSMUST00000023268.14
ENSMUST00000110009.4 |
Arc
|
activity regulated cytoskeletal-associated protein |
chr7_+_44240310 | 11.57 |
ENSMUST00000107906.6
|
Kcnc3
|
potassium voltage gated channel, Shaw-related subfamily, member 3 |
chr8_+_124138163 | 11.56 |
ENSMUST00000071134.4
ENSMUST00000212743.2 |
Tubb3
|
tubulin, beta 3 class III |
chr2_-_68302612 | 11.55 |
ENSMUST00000102715.4
|
Stk39
|
serine/threonine kinase 39 |
chr8_+_94537910 | 11.55 |
ENSMUST00000138659.9
|
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr11_+_80367839 | 11.55 |
ENSMUST00000053413.12
ENSMUST00000147694.2 |
Cdk5r1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chrX_-_156275231 | 11.54 |
ENSMUST00000112529.8
|
Sms
|
spermine synthase |
chr13_-_12121831 | 11.54 |
ENSMUST00000021750.15
ENSMUST00000170156.3 ENSMUST00000220597.2 |
Ryr2
|
ryanodine receptor 2, cardiac |
chr10_+_52566616 | 11.54 |
ENSMUST00000105473.3
|
Slc35f1
|
solute carrier family 35, member F1 |
chr3_-_87907537 | 11.53 |
ENSMUST00000090971.11
|
Bcan
|
brevican |
chr9_+_111140741 | 11.51 |
ENSMUST00000078626.8
|
Trank1
|
tetratricopeptide repeat and ankyrin repeat containing 1 |
chr2_+_31135813 | 11.42 |
ENSMUST00000000199.8
|
Ncs1
|
neuronal calcium sensor 1 |
chrX_-_161426542 | 11.39 |
ENSMUST00000101102.2
|
Reps2
|
RALBP1 associated Eps domain containing protein 2 |
chr11_-_97913420 | 11.36 |
ENSMUST00000103144.10
ENSMUST00000017552.13 ENSMUST00000092736.11 ENSMUST00000107562.2 |
Cacnb1
|
calcium channel, voltage-dependent, beta 1 subunit |
chr11_-_6015538 | 11.35 |
ENSMUST00000101585.10
ENSMUST00000066431.14 ENSMUST00000109815.9 ENSMUST00000109812.9 ENSMUST00000101586.3 ENSMUST00000093355.12 ENSMUST00000019133.11 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II, beta |
chr6_-_77956499 | 11.27 |
ENSMUST00000159626.8
ENSMUST00000075340.12 ENSMUST00000162273.2 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr17_+_27160356 | 11.27 |
ENSMUST00000229490.2
ENSMUST00000201702.5 ENSMUST00000177932.7 ENSMUST00000201349.6 |
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr5_+_125609440 | 11.25 |
ENSMUST00000031446.7
|
Tmem132b
|
transmembrane protein 132B |
chr11_-_116303791 | 11.24 |
ENSMUST00000100202.10
ENSMUST00000106398.9 |
Rnf157
|
ring finger protein 157 |
chr17_-_25789652 | 11.21 |
ENSMUST00000025003.10
ENSMUST00000173447.2 |
Sox8
|
SRY (sex determining region Y)-box 8 |
chr12_-_84745388 | 11.20 |
ENSMUST00000221905.2
ENSMUST00000222422.2 ENSMUST00000095550.4 |
Syndig1l
|
synapse differentiation inducing 1 like |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.1 | 39.4 | GO:0040040 | thermosensory behavior(GO:0040040) |
12.5 | 37.5 | GO:0031283 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
8.9 | 26.8 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
8.5 | 42.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
7.9 | 23.6 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
7.8 | 31.1 | GO:0021750 | vestibular nucleus development(GO:0021750) |
7.7 | 23.2 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
7.6 | 22.9 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
7.6 | 22.8 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
7.1 | 42.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
6.9 | 34.6 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
6.9 | 48.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
6.7 | 66.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
6.6 | 19.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
6.6 | 26.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
6.4 | 19.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
6.1 | 43.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
6.1 | 36.4 | GO:1901660 | calcium ion export(GO:1901660) |
6.0 | 18.0 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
6.0 | 29.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
6.0 | 23.8 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
5.9 | 5.9 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
5.6 | 96.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
5.6 | 22.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
5.3 | 58.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
5.3 | 15.8 | GO:0061107 | seminal vesicle development(GO:0061107) |
5.2 | 10.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
5.2 | 36.1 | GO:1901907 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
5.1 | 15.4 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
5.1 | 30.6 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
5.0 | 20.2 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
5.0 | 5.0 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
5.0 | 9.9 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
4.9 | 59.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
4.8 | 38.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
4.8 | 19.3 | GO:0021586 | pons maturation(GO:0021586) |
4.8 | 14.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
4.7 | 14.1 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
4.6 | 37.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
4.6 | 27.4 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
4.6 | 27.4 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
4.3 | 47.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
4.3 | 12.8 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
4.2 | 4.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
4.1 | 24.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
4.1 | 53.3 | GO:0070842 | aggresome assembly(GO:0070842) |
4.1 | 12.3 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
4.0 | 7.9 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
3.9 | 11.8 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
3.8 | 11.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
3.8 | 19.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.8 | 11.3 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
3.7 | 22.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.7 | 11.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
3.6 | 29.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.6 | 14.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
3.6 | 24.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.5 | 10.4 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
3.5 | 10.4 | GO:0003360 | brainstem development(GO:0003360) |
3.5 | 10.4 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
3.5 | 3.5 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
3.4 | 24.1 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
3.4 | 24.0 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
3.3 | 10.0 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
3.3 | 10.0 | GO:0072034 | renal vesicle induction(GO:0072034) |
3.2 | 29.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
3.2 | 12.9 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
3.2 | 9.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
3.1 | 12.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
3.1 | 62.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
3.1 | 9.3 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
3.1 | 9.2 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
3.0 | 15.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
3.0 | 12.2 | GO:0061744 | motor behavior(GO:0061744) |
3.0 | 8.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
3.0 | 11.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.9 | 44.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
2.9 | 11.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.9 | 26.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
2.9 | 11.5 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
2.9 | 2.9 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
2.9 | 5.7 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.8 | 8.5 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
2.8 | 22.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.8 | 19.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
2.7 | 13.6 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
2.7 | 24.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.7 | 2.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.7 | 29.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
2.7 | 16.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
2.7 | 26.8 | GO:0046959 | habituation(GO:0046959) |
2.7 | 16.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.7 | 13.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.6 | 25.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
2.5 | 15.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.5 | 15.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
2.5 | 5.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
2.5 | 2.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.5 | 9.9 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
2.5 | 12.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.5 | 2.5 | GO:0035332 | positive regulation of hippo signaling(GO:0035332) |
2.5 | 2.5 | GO:0060166 | olfactory pit development(GO:0060166) |
2.5 | 51.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
2.5 | 2.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
2.4 | 21.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
2.4 | 9.6 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
2.4 | 42.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
2.4 | 7.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.4 | 110.9 | GO:0035640 | exploration behavior(GO:0035640) |
2.3 | 9.4 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
2.3 | 16.4 | GO:0051013 | microtubule severing(GO:0051013) |
2.3 | 9.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
2.3 | 11.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
2.3 | 13.9 | GO:0060596 | mammary placode formation(GO:0060596) |
2.3 | 7.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.3 | 6.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
2.3 | 11.4 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
2.2 | 6.7 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
2.2 | 11.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.2 | 15.6 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
2.2 | 33.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.2 | 20.0 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
2.2 | 17.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.2 | 13.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
2.2 | 2.2 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
2.2 | 6.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.2 | 243.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.2 | 6.5 | GO:0022038 | corpus callosum development(GO:0022038) |
2.2 | 2.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
2.2 | 8.7 | GO:0098582 | innate vocalization behavior(GO:0098582) |
2.2 | 10.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
2.1 | 4.3 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
2.1 | 8.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.1 | 2.1 | GO:0033058 | directional locomotion(GO:0033058) |
2.1 | 52.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.1 | 4.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
2.1 | 14.4 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
2.1 | 2.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
2.1 | 4.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.1 | 8.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
2.0 | 6.1 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
2.0 | 32.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
2.0 | 16.0 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
2.0 | 61.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.0 | 7.9 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
2.0 | 68.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
2.0 | 7.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.9 | 5.8 | GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
1.9 | 9.6 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
1.9 | 1.9 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.9 | 1.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.9 | 15.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.9 | 11.2 | GO:0034465 | response to carbon monoxide(GO:0034465) eye blink reflex(GO:0060082) |
1.9 | 3.7 | GO:0007412 | axon target recognition(GO:0007412) |
1.9 | 31.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.8 | 14.8 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
1.8 | 7.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.8 | 12.8 | GO:0009405 | pathogenesis(GO:0009405) |
1.8 | 7.3 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
1.8 | 1.8 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.8 | 14.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
1.8 | 1.8 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
1.8 | 5.3 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
1.8 | 3.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.8 | 22.9 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
1.8 | 3.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.7 | 33.0 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
1.7 | 6.9 | GO:0008038 | neuron recognition(GO:0008038) |
1.7 | 5.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.7 | 13.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.7 | 1.7 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
1.7 | 3.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.7 | 5.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
1.7 | 10.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.7 | 10.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.7 | 3.4 | GO:0072054 | renal outer medulla development(GO:0072054) |
1.7 | 25.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.7 | 5.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.7 | 25.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.7 | 1.7 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.6 | 4.9 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
1.6 | 3.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
1.6 | 9.7 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.6 | 3.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.6 | 4.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
1.6 | 4.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.6 | 3.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.6 | 1.6 | GO:0001964 | startle response(GO:0001964) |
1.6 | 11.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.6 | 11.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
1.6 | 4.8 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
1.6 | 7.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.6 | 66.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.6 | 3.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.6 | 7.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.6 | 28.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.6 | 3.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.6 | 4.7 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
1.5 | 29.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.5 | 16.9 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.5 | 1.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.5 | 9.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.5 | 6.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.5 | 3.0 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
1.5 | 4.4 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
1.5 | 8.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.5 | 4.4 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
1.5 | 18.9 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.4 | 28.9 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
1.4 | 4.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.4 | 18.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
1.4 | 19.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
1.4 | 4.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.4 | 4.2 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
1.4 | 15.6 | GO:0001975 | response to amphetamine(GO:0001975) |
1.4 | 5.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.4 | 22.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.4 | 6.9 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
1.4 | 5.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.3 | 12.0 | GO:0071625 | vocalization behavior(GO:0071625) |
1.3 | 5.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.3 | 28.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.3 | 1.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
1.3 | 4.0 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
1.3 | 4.0 | GO:0098749 | cerebellar neuron development(GO:0098749) |
1.3 | 1.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.3 | 9.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.3 | 5.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.3 | 14.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
1.3 | 9.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.3 | 3.9 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
1.3 | 9.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.3 | 5.2 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
1.3 | 3.9 | GO:0072755 | cellular response to benomyl(GO:0072755) response to benomyl(GO:1901561) |
1.3 | 5.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
1.3 | 9.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.3 | 33.6 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.3 | 2.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.3 | 6.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.3 | 2.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.3 | 1.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.3 | 15.0 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.3 | 7.5 | GO:0099612 | protein localization to axon(GO:0099612) |
1.2 | 21.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.2 | 5.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.2 | 4.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.2 | 46.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.2 | 8.6 | GO:0097501 | stress response to metal ion(GO:0097501) |
1.2 | 73.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.2 | 3.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.2 | 2.4 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.2 | 2.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
1.2 | 3.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.2 | 7.1 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
1.2 | 6.0 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
1.2 | 2.4 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.2 | 4.7 | GO:0072021 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
1.2 | 5.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.2 | 4.7 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
1.2 | 8.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.2 | 8.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.2 | 3.5 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.2 | 7.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
1.2 | 7.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
1.2 | 5.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.1 | 8.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.1 | 3.4 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
1.1 | 45.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.1 | 7.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.1 | 3.4 | GO:1902855 | nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
1.1 | 12.4 | GO:0021794 | thalamus development(GO:0021794) |
1.1 | 4.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.1 | 1.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.1 | 6.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
1.1 | 5.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.1 | 23.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.1 | 21.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.1 | 2.2 | GO:0035934 | corticosterone secretion(GO:0035934) |
1.1 | 5.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.1 | 3.3 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
1.1 | 1.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.1 | 3.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.1 | 1.1 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
1.1 | 9.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.1 | 1.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
1.1 | 1.1 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
1.1 | 13.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.1 | 3.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.1 | 6.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.0 | 1.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.0 | 21.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.0 | 10.5 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
1.0 | 3.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.0 | 2.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
1.0 | 5.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.0 | 34.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.0 | 4.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
1.0 | 9.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.0 | 4.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.0 | 1.0 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
1.0 | 16.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.0 | 5.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
1.0 | 6.9 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.0 | 33.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
1.0 | 34.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 5.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.0 | 3.9 | GO:0035106 | operant conditioning(GO:0035106) |
1.0 | 5.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.0 | 5.7 | GO:0048069 | eye pigmentation(GO:0048069) |
1.0 | 1.9 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.9 | 19.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.9 | 6.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.9 | 14.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.9 | 1.9 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 14.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.9 | 7.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.9 | 25.1 | GO:0007616 | long-term memory(GO:0007616) |
0.9 | 9.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
0.9 | 4.6 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.9 | 7.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.9 | 3.6 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.9 | 16.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.9 | 57.6 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.9 | 6.3 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.9 | 2.7 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.9 | 27.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.9 | 0.9 | GO:0060915 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.9 | 6.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.9 | 23.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.9 | 7.0 | GO:0051775 | response to redox state(GO:0051775) |
0.9 | 12.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.9 | 6.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.9 | 9.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.9 | 10.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.9 | 6.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 1.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.9 | 5.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.9 | 2.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.9 | 1.7 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.9 | 2.6 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.9 | 0.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.9 | 3.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.8 | 0.8 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.8 | 7.5 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.8 | 2.5 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.8 | 6.7 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.8 | 6.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.8 | 9.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.8 | 4.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.8 | 0.8 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.8 | 1.6 | GO:0015825 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.8 | 3.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.8 | 8.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.8 | 6.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.8 | 7.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 6.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.8 | 6.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.8 | 3.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.8 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.8 | 5.6 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.8 | 4.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.8 | 1.6 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.8 | 76.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 10.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.8 | 3.2 | GO:0015755 | fructose transport(GO:0015755) |
0.8 | 3.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.8 | 1.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.8 | 2.3 | GO:0044107 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.8 | 1.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.8 | 5.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.8 | 0.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.8 | 3.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.8 | 1.5 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.8 | 2.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.8 | 26.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.8 | 0.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.8 | 5.3 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.8 | 30.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.8 | 12.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.8 | 0.8 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.8 | 1.5 | GO:1904700 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
0.8 | 1.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.8 | 2.3 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.7 | 2.2 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.7 | 1.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.7 | 0.7 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.7 | 7.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.7 | 2.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.7 | 9.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.7 | 5.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.7 | 12.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.7 | 9.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.7 | 95.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.7 | 8.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 15.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.7 | 2.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.7 | 0.7 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.7 | 2.1 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.7 | 2.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.7 | 2.8 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.7 | 7.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.7 | 4.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.7 | 4.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.7 | 2.1 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.7 | 4.8 | GO:1902961 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.7 | 2.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.7 | 1.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.7 | 10.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.7 | 11.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.7 | 12.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.7 | 6.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.7 | 0.7 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.7 | 4.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.7 | 4.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.7 | 1.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.7 | 2.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.7 | 21.4 | GO:0008542 | visual learning(GO:0008542) |
0.7 | 3.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 8.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 12.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.7 | 0.7 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.7 | 2.7 | GO:0097274 | urea homeostasis(GO:0097274) |
0.7 | 4.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 2.0 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.7 | 18.4 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.7 | 5.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.7 | 6.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.7 | 6.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 0.7 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.6 | 3.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 7.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.6 | 6.4 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.6 | 1.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.6 | 3.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.6 | 0.6 | GO:0021764 | amygdala development(GO:0021764) |
0.6 | 8.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.6 | 5.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.6 | 0.6 | GO:0032098 | negative regulation of response to food(GO:0032096) regulation of appetite(GO:0032098) negative regulation of appetite(GO:0032099) |
0.6 | 2.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.6 | 57.7 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.6 | 2.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.6 | 4.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 2.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.6 | 10.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.6 | 1.8 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.6 | 20.2 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.6 | 1.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 2.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.6 | 2.4 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 9.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.6 | 4.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 10.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.6 | 3.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.6 | 4.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.6 | 2.9 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.6 | 2.9 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.6 | 16.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 4.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.6 | 2.3 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.6 | 3.5 | GO:0030421 | defecation(GO:0030421) |
0.6 | 3.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.6 | 20.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.6 | 1.7 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 1.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 3.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 4.0 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.6 | 0.6 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.6 | 10.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.6 | 1.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.6 | 13.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 2.8 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.6 | 2.8 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.6 | 1.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.6 | 20.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.5 | 3.8 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.5 | 3.8 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.5 | 3.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 3.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.5 | 2.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.5 | 3.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.5 | 4.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.5 | 1.6 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 1.6 | GO:1903912 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.5 | 1.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.5 | 0.5 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.5 | 15.9 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.5 | 5.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 0.5 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.5 | 2.0 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.5 | 1.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 4.0 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.5 | 5.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 5.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.5 | 4.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 4.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.5 | 1.0 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.5 | 6.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.5 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 1.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.5 | 2.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 2.5 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.5 | 4.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 2.9 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.5 | 1.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.5 | 1.5 | GO:0042128 | nitrate assimilation(GO:0042128) |
0.5 | 15.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.5 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.5 | 1.9 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.5 | 1.4 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.5 | 1.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.5 | 3.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.4 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.5 | 6.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.5 | 3.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.5 | 0.5 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.5 | 1.9 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
0.5 | 3.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.5 | 2.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.5 | 1.9 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.5 | 1.8 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 2.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 1.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.5 | 1.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.5 | 1.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 0.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 0.4 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.4 | 4.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.4 | 1.3 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.4 | 1.3 | GO:0031591 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.4 | 2.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.4 | 5.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 2.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 6.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 13.6 | GO:0090662 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.4 | 1.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 0.9 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.4 | 0.4 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.4 | 1.3 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.4 | 18.8 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.4 | 1.3 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.4 | 3.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 6.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.4 | 4.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 0.8 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.4 | 5.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 2.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 1.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 2.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 9.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 5.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.4 | 1.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 13.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 1.2 | GO:0006530 | asparagine catabolic process(GO:0006530) |
0.4 | 2.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.4 | 2.4 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 3.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 8.9 | GO:0031111 | negative regulation of microtubule depolymerization(GO:0007026) negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.4 | 1.9 | GO:0006231 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.4 | 5.8 | GO:0043113 | receptor clustering(GO:0043113) |
0.4 | 7.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 6.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 1.1 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.4 | 1.5 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.4 | 0.8 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 0.8 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.4 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 0.4 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.4 | 0.7 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.4 | 1.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.4 | 3.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 1.8 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.4 | 2.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 9.5 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.4 | 1.1 | GO:0015744 | succinate transport(GO:0015744) |
0.4 | 1.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 1.1 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.4 | 0.7 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.4 | 4.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.4 | 2.2 | GO:0048489 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.4 | 2.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 1.1 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.4 | 7.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 3.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 4.3 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.4 | 1.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 11.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 2.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 1.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.4 | 3.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.3 | 21.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.3 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.3 | 6.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 3.5 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.3 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.3 | 1.0 | GO:0006235 | dTDP biosynthetic process(GO:0006233) dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTDP metabolic process(GO:0046072) dTTP metabolic process(GO:0046075) |
0.3 | 0.7 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 3.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 0.7 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) determination of liver left/right asymmetry(GO:0071910) |
0.3 | 4.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.3 | 1.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 1.0 | GO:0007309 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.3 | 1.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 1.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 1.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.3 | 1.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 0.7 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.3 | 1.6 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.3 | 1.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 3.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.7 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 2.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 1.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 6.1 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.3 | 0.6 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.3 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 1.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 0.9 | GO:2000554 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.3 | 1.6 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.3 | 5.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 4.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 2.2 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.3 | 0.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 4.5 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.3 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 1.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 1.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 3.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.3 | 1.8 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.3 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 12.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.9 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
0.3 | 0.9 | GO:0021660 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.3 | 2.9 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cAMP metabolic process(GO:0030815) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 2.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 3.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 2.9 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 1.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 1.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.3 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.3 | 1.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 0.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.3 | 9.9 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 2.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 1.1 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.3 | 4.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.8 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.3 | 6.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 0.5 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 2.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 4.0 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.3 | 1.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) histone H3-R17 methylation(GO:0034971) |
0.3 | 0.8 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.3 | 2.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 1.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 0.8 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 0.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 9.0 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.3 | 1.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 2.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.3 | 19.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 1.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 1.0 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.3 | 0.8 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.3 | 1.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 2.2 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.2 | 1.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.2 | 7.7 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.2 | 5.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 2.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 6.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 0.5 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.2 | 1.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.0 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 1.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.2 | 1.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 2.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.5 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
0.2 | 4.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 1.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.5 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.2 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.2 | 0.9 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.2 | 2.8 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 4.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 2.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 2.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 2.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 2.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 2.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 1.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 1.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 1.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.6 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 1.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 5.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 1.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 3.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.6 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.2 | 1.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.6 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 5.1 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 3.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 1.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 1.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 1.6 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.2 | 2.6 | GO:0097033 | mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 1.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 1.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 1.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 0.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 1.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.8 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.2 | 0.8 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.2 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.2 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.2 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 0.6 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.2 | 3.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 3.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 0.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 1.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 4.8 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.2 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 6.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 1.5 | GO:0045141 | telomere localization(GO:0034397) meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.2 | 1.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 1.7 | GO:0000423 | macromitophagy(GO:0000423) |
0.2 | 4.9 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.2 | 0.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 2.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 1.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 5.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.5 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.2 | 0.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.5 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.2 | 0.9 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.2 | 0.3 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.2 | 1.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 1.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.8 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 1.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 9.2 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 0.1 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.1 | 2.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.3 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 3.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 1.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 2.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.1 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 8.0 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 0.1 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.1 | 0.8 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 1.0 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 0.5 | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 1.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 12.3 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.1 | 0.1 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 2.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.4 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.1 | 2.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.5 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.2 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.1 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 2.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.4 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.6 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 4.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.5 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.4 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.4 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 1.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.3 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 2.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.1 | GO:2000642 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 2.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.5 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 1.5 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 9.5 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.3 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 6.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 1.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 20.1 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.2 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.3 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 2.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.9 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 2.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 10.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.3 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.1 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.5 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 1.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 1.2 | GO:0030817 | regulation of cAMP biosynthetic process(GO:0030817) |
0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.9 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 2.1 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.1 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.1 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.1 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 3.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.7 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 7.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.4 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 1.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 1.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.1 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.0 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 3.4 | GO:0099536 | synaptic signaling(GO:0099536) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.0 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.3 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.6 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 1.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.7 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.0 | 0.5 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.3 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.7 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.1 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.0 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.0 | 0.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.0 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.0 | 0.1 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.0 | 0.1 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) tRNA transport(GO:0051031) |
0.0 | 0.1 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 1.4 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.8 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.0 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.2 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.6 | 43.9 | GO:0098830 | presynaptic endosome(GO:0098830) |
10.5 | 42.0 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
9.1 | 45.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
5.9 | 17.6 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
5.5 | 27.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.4 | 16.3 | GO:0098855 | HCN channel complex(GO:0098855) |
5.4 | 5.4 | GO:0019034 | viral replication complex(GO:0019034) |
5.1 | 20.5 | GO:1902737 | dendritic filopodium(GO:1902737) |
5.0 | 25.0 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
4.9 | 34.1 | GO:0005955 | calcineurin complex(GO:0005955) |
4.5 | 13.6 | GO:0060187 | cell pole(GO:0060187) |
4.4 | 48.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
4.2 | 12.6 | GO:0016939 | kinesin II complex(GO:0016939) |
4.2 | 234.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
4.0 | 187.4 | GO:0043194 | axon initial segment(GO:0043194) |
3.8 | 252.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.7 | 25.8 | GO:0033268 | node of Ranvier(GO:0033268) |
3.5 | 10.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
3.4 | 171.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.4 | 48.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.3 | 3.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.3 | 49.8 | GO:0031209 | SCAR complex(GO:0031209) |
3.1 | 6.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
3.1 | 12.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.1 | 15.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.0 | 42.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
3.0 | 15.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
3.0 | 11.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.9 | 2.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
2.9 | 20.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.9 | 5.7 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
2.8 | 11.4 | GO:0014802 | terminal cisterna(GO:0014802) |
2.8 | 8.3 | GO:1990031 | pinceau fiber(GO:1990031) |
2.7 | 2.7 | GO:0044301 | climbing fiber(GO:0044301) |
2.7 | 26.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.5 | 259.4 | GO:0043198 | dendritic shaft(GO:0043198) |
2.4 | 12.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
2.4 | 24.2 | GO:0005883 | neurofilament(GO:0005883) |
2.3 | 6.9 | GO:0048179 | activin receptor complex(GO:0048179) |
2.2 | 32.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.2 | 19.4 | GO:0045298 | tubulin complex(GO:0045298) |
2.1 | 46.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.0 | 4.1 | GO:0044305 | calyx of Held(GO:0044305) |
2.0 | 132.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.9 | 17.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.9 | 5.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.8 | 47.1 | GO:1902710 | GABA receptor complex(GO:1902710) |
1.8 | 17.6 | GO:0043083 | synaptic cleft(GO:0043083) |
1.7 | 139.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.7 | 7.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.7 | 650.4 | GO:0097060 | synaptic membrane(GO:0097060) |
1.7 | 5.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.7 | 5.0 | GO:1904511 | cortical microtubule plus-end(GO:1903754) cytoplasmic microtubule plus-end(GO:1904511) |
1.6 | 4.9 | GO:0034705 | potassium channel complex(GO:0034705) |
1.6 | 4.7 | GO:0043291 | RAVE complex(GO:0043291) |
1.5 | 6.2 | GO:0008091 | spectrin(GO:0008091) |
1.5 | 1.5 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
1.5 | 337.2 | GO:0014069 | postsynaptic density(GO:0014069) |
1.5 | 187.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
1.5 | 7.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.5 | 22.0 | GO:0033270 | paranode region of axon(GO:0033270) |
1.5 | 71.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.4 | 5.7 | GO:0033269 | internode region of axon(GO:0033269) |
1.4 | 15.2 | GO:0000235 | astral microtubule(GO:0000235) |
1.4 | 43.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.4 | 9.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.3 | 9.4 | GO:0097513 | myosin II filament(GO:0097513) |
1.3 | 2.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.3 | 2.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.3 | 15.2 | GO:0000801 | central element(GO:0000801) |
1.3 | 32.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.2 | 7.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.2 | 3.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.2 | 10.8 | GO:0097427 | microtubule bundle(GO:0097427) |
1.2 | 69.6 | GO:0043195 | terminal bouton(GO:0043195) |
1.1 | 2.3 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.1 | 10.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.1 | 3.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
1.1 | 7.8 | GO:0044292 | dendrite terminus(GO:0044292) |
1.1 | 5.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.1 | 7.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.1 | 3.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
1.1 | 3.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
1.1 | 3.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.0 | 67.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.0 | 16.8 | GO:0034704 | calcium channel complex(GO:0034704) |
1.0 | 5.9 | GO:0071547 | piP-body(GO:0071547) |
1.0 | 3.0 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
1.0 | 3.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.0 | 11.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.0 | 5.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.9 | 10.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.9 | 12.1 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 14.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 22.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.9 | 17.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.9 | 5.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.9 | 4.5 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.9 | 45.6 | GO:0043679 | axon terminus(GO:0043679) |
0.8 | 23.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.8 | 2.5 | GO:0032545 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
0.8 | 2.3 | GO:0070695 | FHF complex(GO:0070695) |
0.8 | 3.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.8 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.8 | 4.5 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.7 | 1.5 | GO:0044753 | amphisome(GO:0044753) |
0.7 | 20.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.7 | 4.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.7 | 6.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.7 | 37.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 25.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.7 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 66.7 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 4.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 2.0 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.7 | 10.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.7 | 11.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 44.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.7 | 4.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.7 | 2.0 | GO:0070985 | TFIIK complex(GO:0070985) |
0.7 | 9.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 2.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 3.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.6 | 10.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 1.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 3.8 | GO:0070449 | elongin complex(GO:0070449) |
0.6 | 1.9 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.6 | 3.7 | GO:0098793 | presynapse(GO:0098793) |
0.6 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 3.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 5.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 1.8 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.6 | 1.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 1.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 0.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.6 | 3.9 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.6 | 2.2 | GO:0071920 | cleavage body(GO:0071920) |
0.5 | 1.6 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.5 | 1.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 5.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 8.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 1.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 2.4 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 2.9 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 4.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.5 | 1.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 6.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 2.8 | GO:0097433 | dense body(GO:0097433) |
0.5 | 4.6 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.5 | 1.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 1.3 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
0.4 | 21.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.4 | 0.8 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 2.1 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 1.6 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.4 | 2.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.4 | 2.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 11.6 | GO:0097546 | ciliary base(GO:0097546) |
0.4 | 9.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 60.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.4 | 11.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 81.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 1.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 2.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 2.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 2.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 27.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 3.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 1.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 2.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 2.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 20.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 14.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 2.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 6.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 24.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 3.1 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 15.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.3 | 2.8 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.3 | 1.6 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.3 | 14.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 2.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 2.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 2.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 6.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 4.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 3.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 2.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 2.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.9 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.2 | 0.2 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.2 | 61.9 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 2.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 7.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 3.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 2.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 21.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 0.6 | GO:0034455 | t-UTP complex(GO:0034455) |
0.2 | 2.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 8.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.3 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 1.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.2 | 1.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 5.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 4.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 4.5 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 2.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 1.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 1.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.5 | GO:0043512 | inhibin A complex(GO:0043512) |
0.2 | 1.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 4.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 3.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 3.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 3.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 3.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.4 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.1 | 5.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 2.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 2.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.4 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 1.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 1.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 2.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 4.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 3.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 1.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 18.7 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 2.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 1.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 577.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 2.7 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 1.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 1.1 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 2.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.9 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.0 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.4 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.0 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.3 | 27.8 | GO:0001847 | opsonin receptor activity(GO:0001847) |
8.0 | 24.1 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
7.8 | 31.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
7.7 | 46.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
7.0 | 35.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
6.6 | 19.8 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
6.5 | 19.5 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
6.3 | 44.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
6.2 | 24.8 | GO:0038025 | reelin receptor activity(GO:0038025) |
5.2 | 36.1 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
5.0 | 20.2 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
5.0 | 30.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
5.0 | 35.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
5.0 | 20.0 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
4.9 | 29.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
4.9 | 19.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
4.6 | 36.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
4.6 | 27.4 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
4.5 | 27.3 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
4.5 | 45.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
4.4 | 13.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
4.2 | 12.6 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
4.1 | 20.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
4.0 | 44.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.9 | 78.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
3.8 | 38.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
3.8 | 15.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
3.8 | 15.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
3.8 | 33.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.7 | 11.2 | GO:0019002 | GMP binding(GO:0019002) |
3.7 | 7.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
3.7 | 18.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
3.6 | 14.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
3.6 | 35.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
3.6 | 39.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
3.5 | 13.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
3.4 | 13.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.4 | 20.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
3.3 | 26.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.3 | 85.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
3.3 | 19.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
3.0 | 15.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
3.0 | 42.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
3.0 | 12.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
2.9 | 20.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.9 | 8.7 | GO:0016232 | HNK-1 sulfotransferase activity(GO:0016232) |
2.9 | 54.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
2.9 | 43.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.8 | 19.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.8 | 19.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.8 | 14.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.8 | 47.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
2.7 | 2.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.7 | 32.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.7 | 16.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
2.7 | 16.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
2.7 | 26.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.7 | 13.4 | GO:0055056 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
2.6 | 13.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
2.6 | 13.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.6 | 13.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.6 | 18.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
2.6 | 20.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.6 | 17.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
2.5 | 17.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
2.5 | 15.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
2.5 | 14.9 | GO:0004359 | glutaminase activity(GO:0004359) |
2.5 | 9.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
2.5 | 7.4 | GO:0035939 | microsatellite binding(GO:0035939) |
2.4 | 17.1 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
2.4 | 14.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.4 | 4.8 | GO:0070052 | collagen V binding(GO:0070052) |
2.3 | 7.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.2 | 20.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.2 | 8.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
2.2 | 2.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
2.2 | 10.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.1 | 45.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
2.1 | 23.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.1 | 46.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
2.1 | 68.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.0 | 5.9 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
2.0 | 7.8 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.9 | 9.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.9 | 7.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.9 | 13.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.9 | 7.7 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
1.9 | 17.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.9 | 51.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.9 | 15.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.8 | 199.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
1.8 | 5.5 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
1.8 | 12.9 | GO:0097016 | L27 domain binding(GO:0097016) |
1.8 | 11.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.8 | 36.2 | GO:0015643 | toxic substance binding(GO:0015643) |
1.7 | 13.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.7 | 1.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.7 | 8.5 | GO:1990188 | euchromatin binding(GO:1990188) |
1.6 | 4.9 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) mechanically-gated potassium channel activity(GO:0098782) |
1.6 | 4.9 | GO:0051424 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) corticotropin-releasing hormone binding(GO:0051424) |
1.6 | 116.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.6 | 106.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.6 | 32.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.6 | 6.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.6 | 4.7 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
1.6 | 9.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.5 | 7.7 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
1.5 | 21.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.5 | 9.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
1.5 | 6.0 | GO:0035276 | ethanol binding(GO:0035276) |
1.5 | 14.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.5 | 4.4 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
1.4 | 4.3 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
1.4 | 2.8 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
1.4 | 5.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.4 | 4.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
1.4 | 18.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.4 | 8.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.3 | 4.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.3 | 6.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.3 | 12.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.3 | 1.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.3 | 10.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.3 | 3.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.3 | 10.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.3 | 26.4 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.3 | 8.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.2 | 3.7 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
1.2 | 81.5 | GO:0030276 | clathrin binding(GO:0030276) |
1.2 | 3.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.2 | 21.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 16.8 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.2 | 25.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.2 | 7.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.2 | 13.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.2 | 4.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.2 | 29.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.2 | 54.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.2 | 5.8 | GO:0048495 | Roundabout binding(GO:0048495) |
1.2 | 3.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
1.1 | 6.9 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
1.1 | 18.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.1 | 2.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.1 | 2.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.1 | 10.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.1 | 3.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
1.1 | 5.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.1 | 4.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
1.1 | 6.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.1 | 3.3 | GO:0018169 | ribosomal S6-glutamic acid ligase activity(GO:0018169) |
1.1 | 12.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.1 | 3.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.1 | 5.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.1 | 18.3 | GO:0005522 | profilin binding(GO:0005522) |
1.1 | 5.4 | GO:0097001 | ceramide binding(GO:0097001) |
1.1 | 11.8 | GO:0033691 | sialic acid binding(GO:0033691) |
1.1 | 5.3 | GO:0002135 | CTP binding(GO:0002135) sulfonylurea receptor binding(GO:0017098) |
1.1 | 3.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
1.0 | 12.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.0 | 14.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.0 | 3.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.0 | 8.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.0 | 7.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.0 | 3.0 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.0 | 3.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.0 | 4.0 | GO:2001070 | starch binding(GO:2001070) |
1.0 | 4.0 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
1.0 | 2.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.0 | 17.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.0 | 11.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.0 | 2.9 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.0 | 4.8 | GO:2001069 | glycogen binding(GO:2001069) |
1.0 | 23.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.0 | 52.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.9 | 4.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.9 | 3.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.9 | 25.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.9 | 4.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 2.8 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.9 | 0.9 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.9 | 65.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.9 | 41.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.9 | 7.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.9 | 6.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.9 | 1.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.9 | 14.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.9 | 11.5 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.9 | 5.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.9 | 3.4 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.8 | 5.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.8 | 6.7 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.8 | 2.5 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.8 | 2.5 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.8 | 59.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.8 | 5.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 4.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.8 | 11.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 0.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.8 | 87.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.8 | 1.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.8 | 2.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.8 | 9.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.8 | 2.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 3.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.8 | 59.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.8 | 13.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.8 | 7.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 3.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 3.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.8 | 3.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.8 | 54.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.8 | 1.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 5.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.7 | 2.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.7 | 7.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.7 | 17.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.7 | 14.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.7 | 2.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.7 | 30.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 13.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 7.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 2.8 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.7 | 14.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.7 | 2.1 | GO:0004368 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 3.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.7 | 1.4 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.7 | 10.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.7 | 6.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.7 | 23.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.7 | 17.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.7 | 3.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.7 | 1.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.7 | 3.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.7 | 7.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 2.0 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
0.7 | 2.0 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.6 | 1.9 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.6 | 4.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.6 | 2.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.6 | 6.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.6 | 1.9 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
0.6 | 1.9 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.6 | 1.9 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.6 | 2.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.6 | 3.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 1.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.6 | 1.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.6 | 1.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.6 | 12.7 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.6 | 1.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 3.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.6 | 4.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.6 | 27.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.6 | 31.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 11.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 22.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 37.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.6 | 4.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 2.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 4.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.6 | 0.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.6 | 53.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.6 | 3.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.6 | 1.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 3.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 1.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.6 | 1.1 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
0.6 | 8.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.6 | 1.7 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.6 | 6.1 | GO:0008061 | chitin binding(GO:0008061) |
0.6 | 2.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.6 | 4.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 7.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 2.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 1.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.5 | 6.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.5 | 2.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 2.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 2.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 1.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 6.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.5 | 1.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.5 | 2.0 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.5 | 4.0 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.5 | 15.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 1.0 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.5 | 4.0 | GO:0016594 | glycine binding(GO:0016594) |
0.5 | 4.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.5 | 30.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.5 | 4.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.5 | 1.5 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.5 | 5.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.5 | 1.5 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.5 | 4.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 21.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.5 | 1.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 5.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.5 | 8.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.5 | 9.0 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.5 | 8.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 2.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 15.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.5 | 4.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.5 | 2.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.5 | 1.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.5 | 5.0 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.4 | 34.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 4.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 2.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 1.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.4 | 2.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 1.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 1.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 1.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.4 | 95.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.4 | 3.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 2.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 2.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 5.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 13.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 9.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 8.5 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.4 | 4.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 1.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.4 | 2.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 1.2 | GO:0004067 | asparaginase activity(GO:0004067) |
0.4 | 7.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.4 | 4.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 1.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 2.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 3.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 1.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 5.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 3.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.4 | 1.1 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.4 | 1.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 4.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 1.1 | GO:0004133 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
0.4 | 3.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 2.2 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 5.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 1.8 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.4 | 1.4 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.4 | 7.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 2.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 13.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 7.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 2.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 7.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.0 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.3 | 8.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 2.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 1.0 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 2.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 7.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 3.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 3.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 1.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 2.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 2.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 1.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 3.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 8.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 1.2 | GO:0032093 | SAM domain binding(GO:0032093) |
0.3 | 21.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 0.9 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.3 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 3.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 4.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 3.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 0.3 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.3 | 9.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 1.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 0.9 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.3 | 2.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 0.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 1.1 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.3 | 32.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 2.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.3 | 10.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 0.8 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.3 | 1.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 1.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 1.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 0.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.3 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 6.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 8.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 39.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 8.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.7 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.2 | 0.2 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.2 | 2.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 1.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 1.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 5.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 5.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 2.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 1.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.2 | 0.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 13.7 | GO:0015297 | antiporter activity(GO:0015297) |
0.2 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 2.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 2.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 4.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 1.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.8 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.2 | 5.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 6.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.2 | 0.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 12.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 8.1 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 5.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 1.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 3.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 43.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.2 | 0.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 7.5 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 1.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 6.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 2.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 1.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 1.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 91.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 0.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 42.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.4 | GO:0071820 | N-box binding(GO:0071820) |
0.1 | 6.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.6 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 2.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.6 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.4 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.1 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 2.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 2.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 5.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 1.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 7.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 1.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 2.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.3 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 1.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.5 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.9 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 2.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.3 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 2.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 39.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.9 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 2.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 1.2 | GO:0004620 | phospholipase activity(GO:0004620) |
0.0 | 0.1 | GO:0004512 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.0 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 14.6 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 1.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 3.8 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 1.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 1.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 4.1 | GO:0005543 | phospholipid binding(GO:0005543) |
0.0 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.0 | 0.0 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.0 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 8.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
2.4 | 62.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.7 | 38.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.5 | 69.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.2 | 93.6 | PID LKB1 PATHWAY | LKB1 signaling events |
1.1 | 2.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.1 | 56.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.0 | 56.8 | PID RAS PATHWAY | Regulation of Ras family activation |
1.0 | 17.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.9 | 23.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.8 | 59.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.8 | 70.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.8 | 23.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 12.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.8 | 3.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.7 | 32.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.7 | 29.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.7 | 4.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.7 | 48.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.6 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 13.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 35.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.5 | 2.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 15.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 25.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 18.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 5.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 2.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.4 | 3.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 12.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 75.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 0.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 4.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 2.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 8.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 5.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 12.8 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 6.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 6.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 9.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 2.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 3.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 7.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 6.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 80.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
4.2 | 88.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
4.0 | 209.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.0 | 48.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.9 | 48.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.7 | 5.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.7 | 53.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.6 | 63.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.5 | 58.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
2.5 | 89.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.1 | 43.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
2.0 | 99.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
2.0 | 91.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
2.0 | 50.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.9 | 113.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.8 | 22.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.8 | 21.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.6 | 50.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.5 | 20.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.5 | 39.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.4 | 18.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.4 | 2.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.3 | 25.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.3 | 19.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.2 | 53.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.2 | 60.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.2 | 10.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
1.2 | 3.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.1 | 48.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.1 | 214.4 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
1.1 | 3.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.0 | 31.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.9 | 30.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.9 | 16.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.8 | 14.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 15.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 8.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.7 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 12.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.7 | 23.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.7 | 19.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.7 | 6.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.7 | 4.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 15.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 24.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.7 | 9.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.7 | 3.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 21.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 4.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 10.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.6 | 12.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.6 | 7.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 9.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 3.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 8.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 68.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.5 | 24.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 7.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.4 | 4.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 8.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 5.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 7.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 49.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 8.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 11.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 3.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 24.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 5.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 5.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 9.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 5.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 6.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 44.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 7.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 6.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 8.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 4.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 4.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 3.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 2.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 10.5 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 1.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 3.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 3.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 2.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 42.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 3.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 3.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 0.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 7.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 13.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 1.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.5 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |